Paper33859490
GM1 Gangliosidosis: Mechanisms and Management.
Rha AK and 2 others. Appl Clin Genet, 2021. Cited by 67 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. GM1 Gangliosidosis: Mechanisms and Management. Papers, record 33859490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859490
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References184
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25925601 | A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation. | J Pathol | 2015 | https://conductscience.org/library/papers/25925601 | PubMed |
| 2 | 3121133 | Reduced Ca2+ flux in synaptosomes from cats with GM1 gangliosidosis. | Brain Res | 1987 | https://conductscience.org/library/papers/3121133 | PubMed |
| 3 | 28577204 | The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression. | Metab Brain Dis | 2017 | https://conductscience.org/library/papers/28577204 | PubMed |
| 4 | 18524657 | GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. | Mol Genet Metab | 2008 | https://conductscience.org/library/papers/18524657 | PubMed |
| 5 | 26766614 | Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion. | Mol Genet Metab | 2016 | https://conductscience.org/library/papers/26766614 | PubMed |
| 6 | 31481471 | Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. | J Biol Chem | 2020 | https://conductscience.org/library/papers/31481471 | PubMed |
| 7 | 11355658 | GM1-gangliosidosis in Alaskan huskies: clinical and pathologic findings. | Vet Pathol | 2001 | https://conductscience.org/library/papers/11355658 | PubMed |
| 8 | 15687347 | Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. | J Lipid Res | 2005 | https://conductscience.org/library/papers/15687347 | PubMed |
| 9 | 19279282 | MR imaging findings in 2 cases of late infantile GM1 gangliosidosis. | AJNR Am J Neuroradiol | 2009 | https://conductscience.org/library/papers/19279282 | PubMed |
| 10 | 17196562 | Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen. | Brain Res | 2007 | https://conductscience.org/library/papers/17196562 | PubMed |
| 11 | 18818671 | Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain. | Gene Ther | 2009 | https://conductscience.org/library/papers/18818671 | PubMed |
| 12 | 17164772 | Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery. | Mol Ther | 2007 | https://conductscience.org/library/papers/17164772 | PubMed |
| 13 | 12803923 | Neurobiology and cellular pathogenesis of glycolipid storage diseases. | Philos Trans R Soc Lond B Biol Sci | 2003 | https://conductscience.org/library/papers/12803923 | PubMed |
| 14 | 15748609 | G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis. | Clin Chim Acta | 2005 | https://conductscience.org/library/papers/15748609 | PubMed |
| 15 | 29987186 | Teaching NeuroImages: Brain MRI and DaT-SPECT imaging in adult GM1 gangliosidosis. | Neurology | 2018 | https://conductscience.org/library/papers/29987186 | PubMed |
| 16 | 6784662 | GM1 gangliosidosis: phenotypic variation in a single family. | Ann Neurol | 1981 | https://conductscience.org/library/papers/6784662 | PubMed |
| 17 | 19098898 | Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. | Nat Biotechnol | 2009 | https://conductscience.org/library/papers/19098898 | PubMed |
| 18 | 25969757 | Ganglioside biochemistry. | ISRN Biochem | 2012 | https://conductscience.org/library/papers/25969757 | PubMed |
| 19 | 11673388 | Retrospective diagnosis of GM1 gangliosidosis by use of a newborn-screening card. | Clin Chem | 2001 | https://conductscience.org/library/papers/11673388 | PubMed |
| 20 | 20976108 | AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival. | PLoS One | 2010 | https://conductscience.org/library/papers/20976108 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42782580 | Single-nucleus RNA sequencing reveals excitatory and inhibitory neuronal subtype imbalance and its potential regulatory mechanisms in GM1 gangliosidosis. | Genes Genomics | 2026 | https://conductscience.org/library/papers/42782580 | PubMed |
| 42410243 | Brain aging in Type II GM1 gangliosidosis. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42410243 | PubMed |
| 42255911 | Identification of novel compound heterozygous mutations in the GLB1 gene by whole-exome sequencing in a case of infantile GM1 gangliosidosis: a case report. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42255911 | PubMed |
| 42160923 | Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. | Mol Genet Metab | 2026 | https://conductscience.org/library/papers/42160923 | PubMed |
| 42116284 | The effects of circulating proteins and metabolites on diabetic foot ulcer: A Mendelian randomization study and mediation analysis. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42116284 | PubMed |
| 41869395 | An AIEgen-Based Carrier Enables Efficient Cytosolic Delivery of Bioactive Proteins. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41869395 | PubMed |
| 41800148 | Alkaline Phosphatase and Infantile GM1 Gangliosidosis: A Simple Biomarker for a Complex Disease? | JIMD Rep | 2026 | https://conductscience.org/library/papers/41800148 | PubMed |
| 41694796 | Clinical, Radiological, and Genetic Profiles of Eight Patients with Combined Dystonic Manifestation of Type-III GM1 Gangliosidosis: A Video Case Series from India. | Tremor Other Hyperkinet Mov (N Y) | 2026 | https://conductscience.org/library/papers/41694796 | PubMed |
| 41639668 | Lipid alterations in hereditary peripheral neuropathies: common mechanisms in disease heterogeneity? | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/41639668 | PubMed |
| 41315317 | A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms. | NPJ Genom Med | 2025 | https://conductscience.org/library/papers/41315317 | PubMed |
| 41267078 | Burden of caregiving of individuals with GM1 and GM2 gangliosidoses in the United States: a qualitative study. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/41267078 | PubMed |
| 41144932 | Synthesis of an N-Galactosyl Norbornane Aziridine and its Potent Mixed Inhibition of Aspergillus oryzae β-Galactosidase. | Chembiochem | 2025 | https://conductscience.org/library/papers/41144932 | PubMed |
| 40804287 | Novel insights into pathomechanisms of retinal neuronal degeneration and reactive gliosis in a murine model of GM1-gangliosidosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40804287 | PubMed |
| 40462861 | Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases. | Brain Commun | 2025 | https://conductscience.org/library/papers/40462861 | PubMed |
| 40456955 | PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases. | Commun Biol | 2025 | https://conductscience.org/library/papers/40456955 | PubMed |
| 40362688 | Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson's Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362688 | PubMed |
| 40172712 | Spectrum of Genetic Mutations Among Iranian Patients with Gangliosidosis. | Biochem Genet | 2026 | https://conductscience.org/library/papers/40172712 | PubMed |
| 40087722 | Retrospective assessment of clinical global impression of severity and change in GM1 gangliosidosis: a tool to score natural history data in rare disease cohorts. | Orphanet J Rare Dis | 2025 | https://conductscience.org/library/papers/40087722 | PubMed |
| 40016926 | Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/40016926 | PubMed |
| 39925682 | Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/39925682 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33859490
GET https://conductscience.org/api/papers/v1/33859490/references?page=2